The clinical impact of oral iron treatment for anaemia in pregnancy in accordance with current guidance: a prospective cohort study in a maternity unit in the Midlands of England
Prospective cohort study on oral iron's effect on haemoglobin in pregnant women, indicating delivery challenges for IDA treatment guidelines.
Key Points
The overall rate of hematological response to oral iron was 36.5% based on a 10 g/L increase in hemoglobin after 2-4 weeks.
Responders to oral iron treatment exhibited lower median hemoglobin at diagnosis compared to non-responders, indicating variable treatment effectiveness.
Follow-up at clinic appointments showed a significant difference in side effects between responders (85%) and non-responders (95%).
The findings highlight the challenges of implementing national guidelines for oral iron treatment in pregnancy and suggest areas for further research.